Of the total 155 cases of breast cancer, 32 cases (20.64%) showed low/or nil protein expression (+), 53 cases (34.19%) showing moderate (++) expression and in 70 cases (45.17%) showed high (+++) expression of BORIS (Table 2, Figure 4). This evidence concerns the gene CTCFL and breast cancer.